Journal News

From the journals: JLR

Laura Elyse McCormick
Sept. 22, 2023

Linking astrocyte lipid metabolism to microglia activation. Mathematical models of membrane binding. Read about papers on these topics recently published in the Journal of Lipid Research.

 

Linking lipid metabolism to microglia activation

Alzheimer’s disease is characterized by neuronal death in response to the accumulation of protein plaques and tangles. However, nonneuronal cells — including microglia and astrocytes — also play a role in Alzheimer’s

An astrocyte (pink) makes contact with a neuron (blue). In the brain, astrocytes support the function of neurons.
An astrocyte (pink) makes contact with a neuron (blue). In the brain, astrocytes support the function of neurons.

Microglia, the resident immune cells of the brain, modulate neuroinflammation often associated with Alzheimer’s and other neurodegenerative diseases. Astrocytes provide metabolic support to neurons and secrete essential lipids in the form of lipoprotein particles. Lipoproteins also contain the apolipoprotein E, or ApoE, a protein with certain alleles linked to Alzheimer’s disease.

Researchers have identified overexpression of the cholesterol-modifying enzyme cholesterol 25-hydroxylase, or CH25H, in the brains of Alzheimer’s patients. In cell culture models, murine microglia also increase expression of the Ch25h gene following inflammatory stimuli and secrete CH25H’s product, 25-hydroxycholesterol, or 25HC. This extracellular 25HC affects both immune cell signaling and neuronal function. However, although astrocytes play a role in lipid metabolism, scientists did not know if CH25H and 25HC regulate activity in this type of glia.

In new work published in the Journal of Lipid Research, Anil G. Cashikar and colleagues from the Washington University School of Medicine and the University of Texas Health Science Center identified a novel role for 25HC in astrocyte function. Although cultured astrocytes did not express detectable levels of the Ch25hgene, the team showed that these cells can take up extracellular 25HC. Also, astrocytes treated with 25HC showed increased secretion of ApoE-containing lipoproteins.

The authors also identified gene expression changes in astrocytes following 25HC treatment, including the upregulation of genes associated with the liver X receptor pathway and lipoprotein secretion and the downregulation of genes associated with sterol regulatory element-binding proteins and cholesterol synthesis.

Finally, the authors examined cholesterol esterification, a process cells typically use to store excess cholesterol. In 25HC-treated astrocytes, both cholesterol ester levels and the number of lipid droplets, a lipid storage organelle, increased.

Collectively, this work suggests 25HC — a lipid product released by microglia in response to inflammation — can modulate astrocytic gene expression and lipoprotein secretion. Although future research is needed in mouse models, the proposed pathway shows promise in the neurodegeneration field.

 

Mathematical models of membrane binding

Cholesterol — a sterol lipid — is essential for moderating the properties of phospholipid membranes. Cholesterol also interacts with a multitude of membrane proteins and participates in numerous cellular processes.

Researchers often seek to quantify the affinity of proteins for cholesterol. Yet, these measurements usually disregard the fact that most membrane cholesterol is associated with membrane phospholipids, creating competition between proteins and phospholipids for cholesterol. In turn, this complicates the analysis of protein–sterol interactions. 

To address this problem, Yvonne Lange of Rush University and a team of researchers created a mathematical model to examine protein and cholesterol binding in phospholipid membranes. Their results were recently published in the Journal of Lipid Research. This model postulates that cholesterol not bound to phospholipids can readily bind proteins. In addition, the model shows that cholesterol bound to phospholipids can be extracted by the protein.

The team validated their model by simulating the binding of the bacterially derived Perfringolysin O protein to membrane cholesterol. Their results matched previously published experimental data using both artificially created liposomes and cellular membranes.

With this new approach, the authors hope to improve understanding of protein–cholesterol interactions and guide new experiments. In particular, this model may benefit researchers working on ligands with a weak affinity for cholesterol, where competition with phospholipids complicates the interpretation of measurements. 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laura Elyse McCormick

Laura McCormick is a graduate student in the Department of Cell Biology and Physiology at the University of North Carolina at Chapel Hill.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.